379 results on '"Candido, Riccardo"'
Search Results
2. Open questions on basal insulin therapy in T2D: a Delphi consensus
3. Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform
4. Diabete e sindrome metabolica nel paziente con iperaldosteronismo primario
5. Tirzepatide in aggiunta a insulina basale nel trattamento del diabete tipo 2: risultati del trial SURPASS-6
6. Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care
7. Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years
8. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study
9. Assessment of E/A ratio helps emergency clinicians in the management of patients with acute dyspnea
10. 2023 update on Italian guidelines for the treatment of type 2 diabetes
11. Effetto della semaglutide in pazienti obesi con insufficienza cardiaca a frazione di eiezione preservata
12. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
13. Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study
14. Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications
15. Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study
16. Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes
17. Italian guidelines for the treatment of type 2 diabetes
18. Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
19. Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study.
20. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
21. Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control
22. Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
23. Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform
24. Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice
25. Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population‐based study.
26. Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes
27. Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 2 Diabetes: the RESTORE-G Real-World Study
28. Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group
29. Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression
30. The role of logic learning machine in predicting lipid goal attainment among type 2 diabetes outpatients: Results from the AMD annals study group
31. UltraSound cardiac output monitoring in volemic status evaluation in emergency department
32. Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm
33. A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
34. Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study
35. Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study
36. Angiotensin 1–7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro
37. ACE2 deficiency shifts energy metabolism towards glucose utilization
38. Drugs territorialization in the era of PNRR: perspectives, opportunities and considerations from a panel of experts
39. Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes
40. Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction?
41. The incidence rate and prevalence of pediatric type 1 diabetes mellitus (age 0–18) in the Italian region Friuli Venezia Giulia: population-based estimates through the analysis of health administrative databases
42. Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells
43. Italian guidelines for the treatment of type 2 diabetes
44. Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB
45. Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events.
46. Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative
47. Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study
48. Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
49. All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials
50. Usefulness of pocus in the diagnosis of stanford type a aortic dissection with unusual clinical presentation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.